近两年,全球医药健康消费市场正经历着翻天覆地的变化,多个关键国家市场的政策环境也迎来了新的变革。为应对这一新环境,跨国药械企业正加速调整策略,“分拆”“剥离”与“出售”成为了全球瞩目的热点词汇。 继辉瑞、默沙东、葛兰素史克(GSK)、强生等跨国药企(MNC)之后,赛诺菲亦踏上了剥离健康消费品业务的征途。 10月21日,赛诺菲携手私募股权公司CD&R宣布,双方计划携手将Opella打造成一家总部...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.